17-1745346-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_000934.4(SERPINF2):c.116C>T(p.Pro39Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000806 in 1,612,874 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000934.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SERPINF2 | NM_000934.4 | c.116C>T | p.Pro39Leu | missense_variant | 4/10 | ENST00000453066.6 | NP_000925.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SERPINF2 | ENST00000453066.6 | c.116C>T | p.Pro39Leu | missense_variant | 4/10 | 5 | NM_000934.4 | ENSP00000402286 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000264 AC: 4AN: 151610Hom.: 0 Cov.: 28
GnomAD3 exomes AF: 0.00000798 AC: 2AN: 250594Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135790
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461264Hom.: 0 Cov.: 44 AF XY: 0.00000688 AC XY: 5AN XY: 726936
GnomAD4 genome AF: 0.0000264 AC: 4AN: 151610Hom.: 0 Cov.: 28 AF XY: 0.0000406 AC XY: 3AN XY: 73982
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 03, 2021 | The c.116C>T (p.P39L) alteration is located in exon 4 (coding exon 3) of the SERPINF2 gene. This alteration results from a C to T substitution at nucleotide position 116, causing the proline (P) at amino acid position 39 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at